Hiddemann W, Büchner T (1990) Treatment strategies in acute myeloid leukemia (AML). Blut 60: 163–171Hiddemann W, Buchner T. Treatment strategies in acute myeloid leukemia (AML). II. Second line treatment (1990)Blut 60: 163–171
Acute myeloid leukemia (AML) is a cancer that starts in the cells of your bone marrow that make different types of blood cells. It usually starts in a precursor cell to one type of white blood cell. Many of the symptoms of AML are nonspecific, which means they can be caused by several...
- 《Leukemia》 被引量: 279发表: 2007年 Gemtuzumab ozogamicin in the treatment of acute myeloid leukemia Options for treatment of poor-prognosis or relapsed acute myeloid leukemia (AML) remain limited. Gemtuzumab ozogamicin (Mylotarg, Wyeth-Ayerst, Philadelphi... Edward,A.,Stadtmauer - 《Current...
NCCN Guidelines for Treatment of Cancer by Site: Acute Myeloid Leukemia (Version 1.2015) [online], (2015). Dohner, H. et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 115, ...
Fig. 2: Treatment algorithm for AML with mutated IDH1 or IDH2. AML, acute myeloid leukemia; IDH, Isocitrate Dehydrogenase; HMA, hypomethylating agent; IDHi, IDH inhibitor; Allo-HSCT, allogeneic hematopoietic stem cell transplant; MRD, minimal or measurable residual disease. Full size image Table...
Guidelines on the initial diagnostic workup of acute leukemia (AL) have been issued by the College of American Pathologists and the American Society of Hematology (CAP/ASH). [118] Guidelines for the management of acute myeloid leukemia (AML) have been issued by the following organizations: Nat...
急性髓性白血病 ( acutemyeloid leukemia, AML ) 是一类起源于造血干细胞的、以大量遗传缺陷为特征的异质性恶性血液病. 互联网 Methods: Induction regiment ofacute myeloid leukemia( AML ) consisted of mitoxantrone and cytosine arabinoside ( Ara C ). ...
The treatment of acute myeloid leukemia (AML) is divided into two phases: remission induction and consolidation/maintenance. Remission induction chemotherapy is administered to produce a complete remission in the bone marrow. If a complete remission is achieved and no further therapy given, over 90%...
Cells to Enable CAR T Cell Immunotherapy for Acute Myeloid Leukemia," Dr. Saar Gill of the University of Pennsylvania School of Medicine and National Health The team led by Dr. Cynthia E. Dunbar of the Institute pioneered a new approach to treating acute myeloid leukemia (AML) with CAR-T ...
VYXEOS is an intravenous (IV) chemotherapy used for the treatment of adults and pediatric patients 1 year and older with certain types of newly-diagnosed secondary acute myeloid leukemia (sAML): therapy-related AML (t-AML) or AML with myelodysplasia-related changes (AML-MRC). ...